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ABSTRACT                                    
Serum lipids consist of different kinds of lipids in blood. Total cholesterol, high density 
lipoprotein cholesterol, low density lipoprotein cholesterol and triglycerides are the most 
important serum lipids. Hyperlipidemia is the elevated level of serum lipids which is 
considered as an important risk factor for cardiovascular diseases. Dairy products are one of 
the food groups rich in fat especially saturated fat. So many studies have been done to clarify 
the association between dairy products and serum lipids and heart diseases; however, varying 
in results shows need to more studying. 
 A cross sectional survey was done at Kuopio University Hospital. 531 subjects under 71 
years old were selected from hospital discharge list. 412 participants responded to studying 
and finally 253 patients whom did not use lipid lowering drugs were included analyses. 
Patients included were diagnosed with coronary artery bypass grafting, acute myocardial 
infarction, acute myocardial ischemia or percutaneous transluminal coronary angioplasty. 
Data were collected by interview (medical questionnaire) and blood sampling. Dietary intake 
for four days was assessed by food records. SPSS was used to analyze the statistics. 
Mean of TC (total cholesterol), HDL (high density lipoprotein cholesterol), LDL (low density 
lipoprotein cholesterol), TG (triglycerides), energy intake, energy percent (E%) from total fat, 
MUFA (monounsaturated fatty acids), PUFA (polyunsaturated fatty acids), SAFA (saturated 
fatty acids) and also ratio of TC/HDL in patients who did not use lipid lowering drugs and 
also in men and women separately were calculated. Concentrations of serum lipids in men 
were less than in women; however, TC/HDL was less in women. Energy intake (mean±SD) 
was reported 1852 ± 457 Kcal per day for men and 1416 ± 414 Kcal per day for women. 
Energy percent of total fat, PUFA and MUFA were 33.4 ± 7; 5.8 ± 1.9 and 11.4 ± 2.7, 
respectively which were in the recommended range (total fat: 25-35%; PUFA: 5-10%; 
MUFA:10-20%). Spearman correlation coefficient and P-value between dairy products 
consumption and serum lipids were calculated. They showed that there was no association 
between dairy products consumption and serum lipids levels. Participants were divided in 
tertiles of dairy products consumption and any differences of serum lipid levels in low, 
medium and high intake of different type of dairy products was investigated. The data showed 
no significant difference among the consumption groups of total dairy products, liquid milk, 
sour milk, butter or cheese.               
In totality, findings show, there is no association between dairy products and serum lipids in 
subjects who have CHD.            
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ABBREVIATIONS 
 
AMI                     Acute myocardial infarction 
AMIS                  Acute myocardial ischemia 
CABG                 Coronary artery bypass grafting 
CCA-IMT           Common carotid artery intima-media 
CHD                    Coronary heart disease 
CVD                    Cardio vascular disease 
E%                       Energy percentage  
HDL                     High density lipoprotein 
IDL                      Intermediate density lipoprotein 
IHD                      Ischemic heart disease 
LDL                     Low density lipoprotein 
LLD                     Lipid lowering drugs 
MUFA                 Monounsaturated fatty acid 
PTCA                  Percutaneous transluminal coronary angioplasty 
PUFA                  Polyunsaturated fatty acid 
SAFA                  Saturated fatty acid 
SD                        Standard deviation 
TG                        Triglyceride(s) 
UHT                     Ultra heat temperature 
VLDL                   Very low density lipoprotein
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1. INTRODUCTION 
Serum lipids contain mostly of cholesterol carried by lipoproteins (high density lipoprotein 
cholesterol [HDL], low density lipoprotein cholesterol [LDL]), free fatty acids and 
triglycerides carried by very low density lipoprotein (VLDL). Their concentration is related to 
intake of dietary fat quality and could be a risk factor for some chronic diseases like 
cardiovascular diseases (CVDs).  
Increase of fatty foods consumption especially the foods rich in saturated fatty acids is one of 
the resources for increased level of serum lipids. Avoiding or adjusting intake of these fatty 
foods can lead to modification of them toward to lower level and decreasing risk of chronic 
diseases.  
One group of the foods rich in saturated fat is dairy products especially whole fat dairy 
products. Milk is the base material for preparing dairy products. Usually milk contains average 
4.2% fat of which 98% belong to triglycerides and 0.3% to cholesterol (Lindmark 2008). 
Nowadays, some controversy discussions and studies have been done in order to find relation 
between dairy products intake and serum lipids concentration. However, in some last studies 
positive relation was found like in North Karelia Project in Finland (Puska 2010) and in 
contrast negative relation also found (Ravnskov 2010). Some studies have also suggested that 
different type of dairy products have different effects on serum lipids (Marano 2012). 
Generally, nutritionists and medical doctors recommend avoiding of fatty foods in order to 
prevention or stop progressing in serum lipids levels arising because that is one of the most 
important risk factor for CVDs.  
Consumption of dairy products is varying in different countries. Finland is one of the countries 
with high rate of milk and dairy products use.  
The aim of this thesis is assessing the relation between dairy products consumption and serum 
lipid levels. 
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2. LITERATURE REVIEW 
2.1 Serum Lipids 
Major serum lipids are cholesterol and triglycerides. Cholesterol is a waxy steroid which is 
made by liver and found in all foods from animal sources, while triglycerides are primary 
kind of fat which are in the body and could be found in foods and are formed by one glycerol 
molecule and three fatty acid molecules (Harvard medical dictionary 2011). The lipids are not 
water soluble, so they should be transported by an especial carrier called lipoprotein in blood 
circulation. Lipoproteins are combined of triglyceride and cholesterol ester in the core (non 
polar and hydrophobic) which is coated by outer layer content of phospholipid, free 
cholesterol (unesterified) and apolipoproteins (apoproteins) that are polarized. Lipoproteins 
are different by their density so that there are 5 kinds of lipoproteins: chylomicrons, VLDL 
(very low density lipoproteins), LDL (low density lipoproteins), intermediate density 
lipoproteins (IDL) and HDL. Elevated level of these lipids (hyperlipidemia) and lipoproteins 
(hyperlipoproteinemia) and decreasing of HDL in serum could be considered as important 
risk factors for coronary heart diseases (CHD) and stroke (Kingsbury & Bondy 2003).    
HDL is mostly catabolized in liver and kidney and synthesized in liver. It uptakes and 
transfers cholesterol by the reaction called esterification from the body to liver for 
elimination, so it is known as good cholesterol. LDL carries the cholesterol from the liver to 
body cells and coronary arteries which can cause atherosclerosis which can result to 
myocardial infarction or angina, so it is known as bad cholesterol. VLDL transports 
triglycerides from the liver into the body and when triglycerides are removed from it, it 
changes first to IDL and then IDL converts to LDL form. Chylomicrons are made in intestinal 
lumen after digesting of fat. They are the largest lipoprotein particles and rich in triglycerides 
and they could be reason for cloudy appearance of serum after meal (Kingsbury & Bondy  
2003, Harvard medical dictionary 2011).    
LDL cholesterol carries 60-70 percent of total serum cholesterol and has been identified as a 
first target for lowering cholesterol therapy to reduce risk for CHD. HDL and VLDL make up 
20-30 and 10-15 percent of serum total cholesterol, respectively. VLDL and IDL usually 
reform; however, if remain, they could be harmful like LDL. Atherosclerosis usually has been 
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seen in adolescence or early adulthood; however, increasing the cholesterol level in younger 
age develop incidence of CHD in middle age. LDL cholesterol level ≤ 2.58 mmol/l (100 
mg/dl) is considered as an optimal range because of very low association for CHD. Even in 
2.58-3.33 mmol/l (100 – 129 mg/dl) CHD can occur but the probability is less, so this is 
called near optimal. In the range of borderline high 3.36-4.11 mmol/l (130 – 159 mg/dl) 
atherosclerosis can significantly proceed and at level of high 4.13-4.88 mmol/l (160 – 189 
mg/dl) and very high ≥4.91 mmol/l (≥ 190 mg/dl) the risk of CHD will be accelerated. 
Epidemiological studies have shown that high serum HDL cholesterol decreases CHD 
morbidity and mortality, so that one percent decrease in HDL cholesterol increases CHD risk 
by 2-3 percent. Typically women have higher HDL cholesterol concentration than men. HDL 
≤1.03 mmol/l (≤40 mg/dl) is considered as a low and HDL≥ 1.55 mmol/l (≥60 mg/dl) is 
classified as a high HDL. LDL lowering should be the primary target for prevention of CHD 
like lifestyle changes in dietary habits, so that dietary lowering serum cholesterol decreases 
CHD risk as do drugs. It is recommended that serum lipids would be tested every 5 year and 
the result is good if the HDL would be ≥1.03 mmol/l (≥40 mg/dl) and total cholesterol would 
be ≤5.17 mmol/l (≤ 200 mg/dl). Adopting healthy lifestyle habits for lowering LDL 
cholesterol should consist of healthy diet, weight control and physical activity, so that reduced 
intake of saturated fats (less that 7% of total calories) and cholesterol (less than 200 mg/day) 
should be noticed. Furthermore, it is recommended that polyunsaturated fat and 
monounsaturated fat to be up to 10% and 20% of energy intake respectively. Also total fat 
intake should not be more than 30%-35% of total energy intake for adults (FAO/WHO 2008). 
In the meta-analysis including 6356 person-years of follow-up by Gordon and his colleagues 
it was shown that the populations which consumed foods rich in saturated fatty acids and 
cholesterol had a significantly higher risk for CHD and coronary mortality. High fat dairy 
products are one of the major sources of saturated fatty acids. Reduction in intake of such 
kinds of sources is recommended to decrease the saturated fatty acids levels in the body. 
Other lipid that could have harmful effects in our body is trans fatty acids, which have double 
bonds (unsaturated fatty acids) in trans configuration which can be found in animal fats, milk 
and vegetable oils which are partially hydrogenated. Intake of mono- and poly- unsaturated 
fatty acids reduce LDL cholesterol level (Gordon 1995, National Institute of Health 2003).  
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Some researches and randomized studies showed that trans fatty acids increase LDL 
cholesterol level and increase the LDL/HDL ratio (Ascherio et al. 1999) 
It is recognized that there is direct association between saturated fat and serum total 
cholesterol and LDL levels, so that by decreasing 1 E% of saturated fat intake, the level of 
serum cholesterol will be declined by 0.04 (Mensink, Katan 1992) – 0.07 (Keys et al.1965) 
mmol/l and by every percent increase in calories from saturated fatty acids, the LDL level will 
be increasing by 2% and vice versa. Different saturated fatty acids have different effects on 
serum lipids; for instance, stearic acid has the least effect and myristic acid probably has the 
most potent elevating effect on cholesterol (Kris-Etherton & Yu 1997).   
2.2 Dairy Products 
Dairy products usually have been made from bovine milk; however, in some places and 
seasons could be made also from other mammals like goat, sheep, buffalo, yak, etc. Not only 
compositions of milk in mammals are different but also in every mammal also could be 
different because of difference in race, environmental and breeding and lactation conditions 
and also season.  
Analysis has been done on Swedish bovine milk and showed that bovine milk consists of 87% 
water, 4.2% fat, 4.6% lactose, 0.8% minerals and 0.1% vitamins.  About 98% of milk fat is 
triglycerides and also 0.3% belongs to cholesterol. About 25% of fatty acids in milk are 
monounsaturated and 2.3% polyunsaturated and 2.7% trans fatty acids. Other fatty acids are 
saturated so that it has been shown in Swedish dairy milk of 69.4% saturated fatty acids and 
30.6% unsaturated fatty acids. Usually in summer, amount of saturated fatty acids are more 
than in winter and opposite for unsaturated fatty acids. Palmitic acid (16:0) approximately 
contributes 30%, myristic acid (14:0) 11% and stearic acid (18:0) makes up 12% of total fat 
weight. Oleic acid (18:1) contributes 23.8% of the total fat amount. Linoleic acid (18:2) and 
α-linolenic acid (18:3) are the main polyunsaturated fatty acids. There are 2.3 times more 
omega-6 poly-unsaturated fatty acids than omega-3 fatty acids in bovine milk. Also vaccenic 
acid (18:1,11t) and rumenic acid (cis9-trans-11 conjugated linoleic acid) which belong to 
trans fatty acids exist in bovine milk (Lindmark  2008). 
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2.3 Dairy products consumption  
Milk consumption per person varies in countries; however, in European countries it is more 
than other continents so that according to the report of International Dairy Federation (bulletin 
423/2007), Finland in 2006 had the highest milk consumption rate in the world with 183.9 
liters per person per year and China had the lowest rate with 8.8 liters per person per year. 
Greece with annual 28.9 kg cheese consumption and France with 7.3 kg butter consumption 
were also top countries for those dairy products consumption (Goff 2012). Norway has 
declined in fluid milk consumption in two last decades before 2002 although the 
advertisements` expenditure was higher by dairy industrials (Rickertsen 2002). Diet is 
changing in developing countries according to the rise in income, so that the rate of dairy 
product consumption rose by 60% between 1954 - 1966 and 1997 – 1999. In these countries 
the demand for dairy products is predicted to raise, so that it will rise from 20 million tons per 
year in 1997 – 1999 to 39 million tons per year in 2030 (FDA 2005).  
2.3.1   Changes in dairy products consumption in Finland  
Since the cardiovascular mortality was so high in Finland in 1960s, some changes in dietary 
habits have been planned and done, so that significant reduction in mean serum total 
cholesterol by 18% average has been seen by changing dietary habits from 1972 to 1997. 
Saturated fatty acids intake decreased from 21 E% in 1972 to 15 E% in 1997 and poly-
unsaturated fatty acids increased from 3 E% to about 6 E% since 1972. One of the main 
changes in diet was in behavioral level for butter consumption (spread on bread) from 90% to 
10%. Also margarine and soft oil were used in exchange of butter in cooking and baking. Low 
fat and skimmed milk were introduced as healthier in exchange of whole milk. The change in 
dietary habits resulted in decreased intake of saturated fatty acids and cholesterol and it 
resulted to significant decrease of 85% in CHD mortality in age group of 35 – 64 years old. 
(Vartiainen et al. 2000, Puska 2010). Nowadays, consumption of milk has been noticed in 
Finland especially for school students, so that percentage of school milk consumption by 
students has been dedicated about 5% of total liquid milk consumption in Finland. Skimmed-
milk, semi skimmed-milk, low-lactose and fortification with vitamin D are the specifications 
of the milk distributed in schools (Urho 2005).  
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Dairy productions usually follow by requests and some changes has been seen in Finnish 
productions from January 2007 till January 2012, so that production of yogurts, low fat milk 
[ultra heat temperature (UHT) type] and whole fat milk (UHT type) have been increased; and 
cheeses almost without changes and low-fat milk (pasteurized), non-fat milk (UHT type) and 
butter has been decreased. Also production has the highest rate in May and the lowest in 
November every year (Statistics Finland 2012) 
2.4 Dairy products, serum lipids and risk of cardiovascular diseases 
Dairy products contain different nutrients and constituents because of their production 
(additives, bacterial types used, fat percent, processing method, etc.), ripening time and 
method. There are some kinds of dairy products in point of fat view. Fat free, low fat and 
whole fat are 3 kinds of dairy products from fat percent view.  
Full fat dairy products increase coronary heart diseases and obesity because they are 
significant sources for saturated fats. As it has been seen, large reduction in CHD mortality 
has happened in North Karelia and also in other places in Finland which has related to 
decreasing in serum cholesterol level. The reason was reduction in CVD risk factors (serum 
cholesterol, smoking and blood pressure), mainly reduction of cholesterol level because of 
reducing of consumption of whole fat dairy products and also because of decline in total 
energy intake from saturated fat which has been reduced from 21% to 14% and increasing of 
poly-unsaturated fatty acids from 3.5% to 5% in 25 years studying in North Karelia from 
1972 - 1997. Average of saturated fat consumption in 10 selected countries belonging to 
European Union was 13.1% of energy which is higher than optimal consumption of less than 
10% (WHO 2008).  
According to the research in Milan – Italy as a case-control study on 507 cases with median 
age 61 years investigated the effects of some dairy products including whole, semi-skimmed 
and skimmed milk, mozzarella and ricotta and other cheeses and yogurt on risk of acute 
myocardial infarction (AMI). The odds ratio of AMI for non milk drinkers compared with 
milk drinkers (7 cups= 1575 ml per week or more) was 0.78 (95% CI, 0.54 to 1.12). Yogurt 
consumption (7cups = 875 gram or more per week) was associated with, odds ratio 0.55 (95% 
CI, 0.32 to 0.95) for AMI risk. Also odds ratio for cheese consumption (more than 350 gram 
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per week) was 0.77 (95% CI, 0.54 to 1.11).  The results suggest that consumption of cheese 
and milk does not increase the risk of coronary heart disease. In some American studies 
cheese has been associated with increased risk of AMI; however, despite of high consumption 
of cheese in Italy, it is possible this amount is not enough to see direct association observed in 
the U.S.A (Tavani et al. 2002).  
2.5 Effects of different individual dairy foods on plasma lipids 
In considering the individual dairy foods importance because of differences in compositions 
and also in complexity like cheese, yogurt and milk, some of the dairy foods have been 
studied.  
2.5.1 Butter   
Between all dairy foods, in metabolic studies, butter has the least controversial opinion to 
raise the LDL cholesterol concentration because of the fatty acids composition which 
influences LDL cholesterol level (Nestel et al. 2008). A study was done in The Netherlands 
which demonstrated that by replacing 10% of calories from butter by soft low-trans 
margarines (but not by hard high-trans), total cholesterol decreased by 0.25 mmol/l, LDL by 
0.20 mmol/l and decreased the ratio of TC/HDL which is one of the good indicator for health. 
Also it showed by replacement of 30 gr of butter with soft low-trans margarines, risk of 
coronary heart diseases reduced by 10% (Zock & Katan 1996). Some clinical trials have 
shown that butter not only increases the LDL cholesterol concentration, but also modestly 
increase the HDL cholesterol, so it causes small increase in the ratio of total cholesterol to 
HDL cholesterol which is bigger risk factor rather than LDL or HDL lonely (Mensink et al. 
2003, Shai 2004).    
In a study in Sweden the effect of daily intake of butter milk formulation enriched in globule 
of milk fat examined on blood lipids (total cholesterol, HDL, LDL and TG) in healthy 
volunteers in a four week intervention in test and placebo groups. The indicator components 
were sphingolipids (SL) and in particular sphingomyelin (SM) which exist in milk fat polar 
lipids. To determine exact analysis, real test drink was prepared which contained 20% milk 
phospholipids originating from butter oil production for test group and placebo drink was 
prepared which contained of 1/3 butter oil and 2/3 by egg phospholipids but the same amount 
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for cholesterol as the test group for placebo group. Although sphingomyelin inhibit the 
cholesterol absorption in rats (Nyberg et al. 2000) and sphingolipids decreased plasma 
cholesterol and triglycerides in mice (Duivenvoorden et al. 2006). The results showed no 
significant lowering in plasma lipids after 4 weeks treatment (Ohlsson et al. 2009).   
2.5.2 Cheese 
It seems that cheese intake compared with some other dairy foods consumption has different  
effects on serum lipids, so that three different studies has been done lately in Norway, 
Denmark and Australia, which show the similar results without discrepancies. They found 
that cheese had minor raising effect on LDL level compared to other dairy products like butter 
which was modified by adding lactose and protein to make similar structure with cheese 
(Nestel et al. 2008).  
Consumption of cheese opposite of butter has no effect on cholesterol level as Danish 
researchers found out even 13% of their calorie intake would be from hard cheeses. One of 
the reasons might be related to their calcium content which boosts the fat excretion; however, 
some researchers link it with the fermentation. The micro organisms which are used for 
cheese making have a role to change the fatty acids into digestive forms. They also may 
dismantle the cholesterol (Marano 2012).  
To confirm the role of dairy calcium on fat excretion, it could be referred to two studies which 
were done in Denmark. By calcium enrichment and fortification, fecal fat excretion increased 
2.5 folds during the short trial period with normal protein intake; however, there were no 
effect on fat oxidation, cholesterol, free fatty acids and triglycerides (Jacobsen et al. 2005, 
Bendsen et al. 2008). Analogous result was seen in an Australian investigation showing 
neutral effect of calcium on total cholesterol, HDL, LDL and TG concentrations (Daly et al. 
2009) 
2.5.2.1 Compare between cheese and butter consumption on serum lipids 
It seems that consumption of cheese should lead to increase of serum cholesterol 
concentration and risk of CVD (coronary vascular disease) because of high content of 
myristic and palmitic acids; however, this result is unclear for fermented dairy products like 
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cheese so that in a prospective cohort study done lately in the Netherlands found no relation 
between cheese consumption and ischemic heart disease (Goldbohm et al. 2011).  Also in a 
randomized crossover intervention study for two 6-weeks` periods which 13% of the subjects` 
energy intake was supplied from cheese and butter and a 14-day run-in period which subjects 
used habitual diets, the result showed that cheese consumption resulted in lower total, LDL 
and HDL cholesterol than butter intake. The daily intake of cheese (27% fat) was 143 grams 
and 47 grams for butter [butter has 80-82% fat (Goff 2012)] both produced from cow milk, so 
the amount of fat from both diets were equal. One possible reason for this effect of cheese 
could due to high calcium content. After 3 and 6 weeks intervention blood lipids were 
measured. After cheese consumption, there was a 6.9% decrease in LDL cholesterol 
concentration and 5.7% lower total cholesterol and also decrease in HDL cholesterol 
compared with butter period. After butter period higher concentration in total and LDL 
cholesterol has observed; however, there was no difference in serum triglycerides after cheese 
and butter consumption. These results are supported by three other studies which were done 
before (Biong et al. 2004, Tholstrup et al. 2004 and Nestel et al. 2005). An interesting point 
was that, there was no increase of LDL cholesterol level in cheese period in which the total 
and saturated fats were higher than run-in period. The hypothesis of calcium affecting fat 
excretion was also rejected because as the fat excretion did not significantly differ in cheese 
and butter periods. Fermentation is the strongest candidate for abovementioned results; 
however, for recognition of the mechanism, more research will be needed (Hjerpsted et al. 
2011). 
2.5.3 Yogurt 
Yogurt is one of the fermented dairy products which has been made in different methods, 
cultures, fat percent, texture, tastes, simple or mixed with additives like fruit, vegetables or 
spices. Several studies have been done in Iran to explore relation between probiotics dairy 
products and serum lipids.  
One single blind and randomized crossover study has performed in Iran in order to find the 
cholesterol lowering effect of probiotic yogurt in comparison with traditional yogurt 
consumption in subjects without CHD, diabetes, nephritic syndrome, hypothyroidism and 
obesity and only with mild to moderate hypercholesterolemia (total cholesterol equal with 
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5.17 - 7.76 mmol/l).  In traditional yogurt, Streptococcus thermophilus and Lactobacillus 
bulgaricus are used; however, for probiotic yogurt, Lactobacillus acidophilus and 
Bifidobacterium lactis which normally exist in the gut, are used in addition to traditional 
yogurt bacteria. Probiotic yogurt resulted in a significant reduction in total serum cholesterol 
in comparison with traditional yogurt (Ataie-Jafari et al 2009).  
The effect of probiotics was also studied in Iran and the same result as in healthy people 
mentioned above was achieved, so that in probiotic yogurt consumers there was 5.54% 
decrease in total cholesterol, 7.45% decrease in LDL-C, decrease in TC / HDL and LDL/HDL 
have seen in compared with control group; however, there was no significant changes in HDL 
and TG serum level (Ejtehad et al. 2011). 
Other Iranian studies have also confirmed upper mentioned result for consumption of 
probiotic yogurt and its cholesterol lowering effect because of several mechanisms. First, 
associated deconjugated bile acids in bile salt hydrolase catalysis. Because the cholesterol is 
used for the synthesis of bile acids, so by using cholesterol for synthesizing new bile acid lead 
to decrease in serum cholesterol level. The next mechanism is that cholesterol is needed to 
stabilize the probiotic cell membrane, so by binding the cholesterol to cell walls in intestine 
the serum cholesterol level will be declined.  Other mechanism related to probiotics which 
cause to converse the cholesterol into coprostanol. Finally, short chain fatty acids which have 
been produced by probiotics, prohibit cholesterol synthesis in liver or redistribution of 
cholesterol from blood into the liver (Baroutkoub et al. 2010, Homayouni et al. 2012).      
Usually after consumption of high fat yogurt or other foods, serum lipids especially TG and 
chylomicron will be elevated for a long time because of low level of lipase activity. In a 
Japanese study, the suppressive effect of guar gum on postprandial TG has investigated. The 
result showed that, partially hydrolyzed guar gum affected to the speed and rate of fat 
absorption more than TG removal from the serum which lead to decreasing in TG serum level 
and decreasing the coronary artery disease risk factor consequently (Kondo et al. 2004).    
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2.6 Association between yogurt, cheese and milk consumption and thickness of common 
carotid artery intima-media (CCA-IMT) and cardiovascular risk factors 
Dairy products contain of saturated fatty acids; however, some data deemed they could have 
some beneficial outcomes on cardiovascular system and diminish the risk factors. 
Consumption of yogurt, cheese and milk was investigated in a cohort of elderly women aged 
over 70 years living in Perth, Australia for 3 years. Results from food frequency questionnaire 
(to determine the dairy consumption types and content), ultrasound [to assess the common 
carotid artery intima-media (CCA-IMT)] and also measure of serum lipids and blood pressure 
elucidated some assumptions for positive relation between some dairy products consumption 
and CVD risk factors. Findings showed that, high consumption of yogurt (more than 100 g/d) 
but not cheese and milk was significantly associated with lower CCA-IMT and higher HDL 
cholesterol, but there was no relation with LDL cholesterol and triglycerides. It was found a 
similar result for high consumption of yogurt but not milk and cheese consumption, and lower 
risk for acute myocardial infarction (Tavani et al. 2002). Also there has been found a positive 
association between high consumption of yogurt in a long-time and increased HDL 
concentration (Kiessling et al. 2002). To make final and official recommendation, more 
clinical and observational trials are needed (Ivey et al. 2010).  
2.7 Role of biomarkers in dairy fat intake assessments 
As defined, biological markers are the “biological molecules that represent health and disease 
states” (Ham et al. 2012). In other definition, biomarker is “distinctive biological indicator of 
an event, process or condition” (Harvard Medical dictionary 2011), so a biomarker is a 
substance and parameter which examine the function of organ and measure improvement of 
disease or treatment with respect to intake or metabolism of dietary compositions (Potischman 
2003) .    
2.7.1 Biomarkers of milk fat and risk of myocardial infarction         
Pentadecanoic acid (15:0) and heptadecanoic acid (margaric acid 17:0) are two saturated fatty 
acids which are known as serum milk fat biomarkers. It seems that biological markers could 
be more objective than self reported intake (Cantwell 2000, Sun et al. 2007).   
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Evaluating the potential risk for relation between the serum milk fat biomarkers with odds of 
the first myocardial infarction was done in a prospective case-control study in northern 
Sweden. The results showed that the proportion of biomarkers were significantly less in cases 
than in controls and therefore the odds ratio for first MI was decreased too (0.7 – 0.8). The 
proportions of biomarkers and sum of them were negatively related in serum concentrations 
of tissue-type plasminogen activator, triacylglycerols, plasminogen activator inhibitor-1 and 
leptin, so it supposed to adverse role of milk fat in CHD, especially the first acute myocardial 
infarction in this study (Warensjo et al. 2010). In detail, the odds ratio for both men and 
women was descending for cheese and fermented milk consumption as was confirmed in 
Norwegian study (Biong et al. 2006 ) also. However, after multivariable adjustment for 
confounders, fermented milk intake lost it`s significant trend for women. By data which have 
got by biomarkers, the results showed that cheese intake was conversely associated with AMI 
in both sexes and fermented milk only in men. These findings should be interpreted cautiously 
because some other factors like lifestyle factors may be involved to the observed associations 
(Warensjo et al. 2010).   
2.7.2 Biomarkers of milk fat and risk of ischemic heart diseases  
In a prospective case control study the validity of dairy products biomarkers and assess the 
relation between plasma and erythrocytes` biomarkers with risk of IHD has explored in the 
U.S. The results showed that pentadecanoic acid 15:0 and also trans 16:1 n-7 could be used as 
a biomarker because they correlated with dairy fat intake. That study also discerned that high 
fat dairy products like butter and whole milk have positive association with ischemic heart 
diseases and even mortality after adjusting for established IHD risk factors and other fatty 
acids in plasma, so that the women in the lowest tertile of  pentadecanoic acid 15:0 had two 
times lower IHD risk than women in the highest tertile (Sun et al. 2007).   
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3. AIM AND QUESTIONS  
Aim of this study is to assess the association of dairy products intake on serum total 
cholesterol, HDL cholesterol, LDL cholesterol and triglycerides levels among coronary heart 
patients under 71 years old in a cross-sectional setting in Finland. 
This following question will be studied: 
- What is the association between dairy products (total dairy products, butter, 
cheese, sour milk, liquid milk and other dairy products) consumption and 
serum total cholesterol, HDL cholesterol, LDL cholesterol and triglycerides 
levels? 
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4. SUBJECTS AND METHODS 
4.1 Subjects 
A cross-sectional survey was carried out at the Kuopio University Hospital. Subjects in this 
study have chosen of patients (531 participants consist of 355 male and 176 women) with 
CHD, age under 71 years old which were identified from the hospital discharge list. 
Participants had been hospitalized 6 - 48 months before starting the survey. They have 
registered in four CHD diagnoses consisting of coronary artery bypass grafting (CABG) with 
109 participants, percutaneous transluminal coronary angioplasty (PTCA) with 106 
participants, acute myocardial infarction (AMI) with 101 participants and acute myocardial 
ischemia (AMIS) with 99 participants. First, 125 participants were identified for each group 
(except for AMI which have identified 150 because of higher expected mortality in this 
group) but some of the participants did not participate because of refuse, no response to 
invitation, travel or death, so, final participants in this study were overall 415 from 531. In my 
thesis, 252 participants from 415 which did not use lipid lowering drugs were included. Lipid 
lowering drugs may affect the association studied, so, the participants who have used them, 
were excluded from the analysis.   
 
4.2 Methods 
Research method was quantitative. Data collection was done in 2 stages. One stage by review 
of medical hospital records and the second stage by interview and questionnaires by physician 
and clinical measuring consisting of height, weight, blood pressure and blood sampling was 
done by trained nurses and also food assessments like food record and dietary questionnaire 
by nutritionist, so the necessary materials for clinical assessment were used. The second stage 
was done at least 6 months after the hospitalization.  
 
4.2.1 Clinical assessments 
Weight and height were measured with light clothes and no shoes. Blood pressure was 
measured in sitting position and after 5 minutes resting.  
Blood sampling was done at 8:00 – 10:00 after 12 hours fasting. Fresh serum was used for the 
analysis total and lipoprotein lipids. VLDL was removed from lipoproteins by 
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ultracentrifugation. Then, LDL was precipitated from the infranatant fluid and HDL 
cholesterol was analyzed from the remaining supernatant. At the end, the LDL cholesterol 
was calculated by subtracting the HDL cholesterol from amount of HDL+LDL cholesterol in 
the infranatant fluid (Erkkilä 2001).         
 
4.2.2 Dietary assessment 
Four-day food record (three weekdays and one weekend days) was completed by participants 
at home according to the related instructions sent by mail. The forms were returned in 
interview and checked by nutritionist and missing information was completed after checking. 
Energy and nutrient intake were calculated using Micro-Nutrica dietary analysis software 
(Finnish Social Insurance Institute, Turku, Finland). 
 
4.2.3 Medical questionnaire 
A physician interviewed the participants with a specific questionnaire to determine 
information about education, medication use, smoking habits and cardiac history.    
 
4.3 Statistical methods 
Statistical analyses were performed by SPSS statistical program for windows version 19. 
Kolmogorov-Smirnov test was done to determine the normality of variables before starting 
the analyses. Non-parametric tests were used because of not normal distribution of variables. 
Measurement of linear and strength relationship between two variables were done by 
Spearman correlation coefficient (r). Main comparisons were done for tertile categories of 
dairy products consumers by using analysis of variance (ANOVA). The results for continuous 
variables were represented as mean±SD. Value of P<0.05 was considered as statistically 
significant.  
 
4.4 Ethical issue  
The study was approved by the ethics committee of the Kuopio University Hospital and 
Kuopio University and all the participants gave informed consent to participate the study. 
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5. RESULTS 
5.1 Characteristics 
The participants were categorized in four groups in considering their illnesses. First, 531 
participants were selected. Because of some reasons like travel, rejected participation and 
death, 412 participants remained of which 253 participants who did not used lipid lowering 
drugs (LLD) were selected finally for this study. Participants who used lipid lowering drugs 
were excluded because using lipid lowering drugs could affect to the results on the association 
between dairy use and serum lipids levels and the characteristics for the participants who did 
not use lipid lowering drugs has been shown in table 1. In all participants, 61.5% of men and 
60% of women did not use lipid lowering drugs. Average age for LLD non-users was a little 
more than all participants. Patients with CABG and PTCA diagnoses used more often lipid 
lowering drugs (55% and 58.3%, respectively) than AMI and AMIS (22.2% and 21.5% 
respectively) diagnoses.   
 
Table 1. Participants Characteristics 
Variable                                      All (n=415)                                LLD
1
 non users (n=253
2
)                      
 
Age (Mean ± SD)                        60.9 ± 8.4                                              62 ± 8.1  
 
Gender (M-F)                                285-130                                                 175-78 
  
Diagnosis n (%) [M-F] :          
 CABG
3
                                    109 (26.26) [87-22]                             49 (19.44) [38-11] 
 AMI
4
                                       101 (24.33) [75-26]                             79 (31.34) [57-22] 
AMIS
5
                                      99 (23.85)   [57-42]                             79 (31.34) [46-33]
 
PTCA
6
                                     106 (25.54)  [66-40]                             46 (18.25) [34-12] 
 
 
1
Lipid Lowering Drugs    
2
60 persons of CABG (55%);   60 persons of PTCA (58.3%); 22 
persons of AMI (22.2%) & 20 persons of AMIS (21.5%) were used of Cholesterol lowering 
drugs   
3
 Coronary arteries bypass grafting   
4
 Acute myocardial infarction   
5
 Acute 
myocardial ischemia   
6 
Percutaneous transluminal coronary angioplasty 
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5.2 Serum lipids and intake of dietary fatty acids 
Serum lipids was calculated averagely in participants who did not used lowering medicines 
and it has shown that all sections (consist of total cholesterol, HDL cholesterol, LDL 
cholesterol and triglycerides) were higher in women than men as it shows in table 2. The ratio 
of TC/HDL is bigger in men than in women. Energy intake percent (E%) for different type of 
fats was calculated also.  
 
 Table 2. Participants` serum lipids and lipids intake for who did not use lipid lowering drugs 
          Variable                        Overall (n=253)           Men (n=175)              Women (n=78) 
 
Total Cholesterol (mmol/l)         6.31 ± 1.14
1
                6.11 ± 1.14                    6.78 ± 1.00        
   
HDL Cholesterol (mmol/l)        1.21 ± 0.30                 1.15 ± 0.26                    1.36 ± 0.33 
 
LDL  Cholesterol(mmol/l)         4.45 ± 0.95                 4.33 ± 0.96                    4.74 ± 0.88 
 
Triglycerides(mmol/l)                1.92 ± 1.19                 1.89 ± 1.20                    1.99 ± 1.16 
TC/HDL                                              -                               5.29                               4.96 
Energy intake (Kcal/day)            1731 ± 511                1852 ± 457                     1416 ± 414   
Cholesterol intake(mg/d)              220 ± 89                    232 ± 89                         191 ± 81                    
Total Fat (%E
2
)                            33.41 ± 7                   33.83 ± 6.9                     32.35 ± 7.1 
SAFA
3
 (%E)                                13.37 ± 4                   13.37 ± 4.2                     13.39 ± 3.9 
MUFA
4
 (%E)                             11.41 ± 2.7                 11.63 ± 2.7                      10.90 ± 2.7 
PUFA
5
 (E%)                                5.82 ± 1.9                    6.00 ± 2                          5.35 ± 1.6 
 
1
Mean ± SD   
2
Energy intake percentage   
3
Saturated fatty acid   
4
Monounsaturated fatty acid 
5
Polyunsaturated fatty acid 
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In table 3, correlation between intake of saturated fatty acids (g/d and E%) and different type 
of serum lipids was investigated.  Dairy products are one of the important food resources of 
saturated fatty acids. As there can be seen, there is no significant correlation between 
saturated fatty acids intake and none of serum lipids.  
Table 3. Correlation and association between saturated fatty acids intake and serum lipids 
                                                     TC                  HDL                  LDL             Triglycerides 
Saturated fatty acids(g/d)      -0.081- 0.2052      -0.03- 0.658             -0.08- 0.200               -0.01- 0.868    
Saturated fatty acids(E%)      0.231- 0.7182        0.10- 0.113             -0.21- 0.747                 0.33- 0.617 
1
Correlation coefficient (r)        
2
P-Value 
 
5.3 Dairy products consumption                
As the intake of dairy products in patients is shown in table 4, there were noticeable 
differences between usages of them, so that average intake of butter was the least proportion 
(only 11 gram per day) and liquid milk was the most intakes (equal with 313 gram per day). 
Almost in every four groups (CABG, PTCA, AMI and AMIS) intake of total dairy products 
were equal.                       
                                                                                                                          
Table 4. Dairy intake of participants who did not use lipid lowering drugs 
  Dairy product, g/d                             Mean                                SD 
 Total dairy products                            455                                  238 
             Butter                                        11                                   16                                  
             Liquid Milk                              313                                 227 
             Sour Milk                                  93                                  137 
             Cheese                                       21                                   23 
            Other milk Products                   29                                   45       
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5.4 Correlation between dairy products consumption and serum lipids  
To find any significant associations between the data and to test linearity of associations 
between the variables (serum lipids and dairy products) P-value and correlation coefficient 
was calculated (table 5). As it seems, none of the P-values and correlation coefficients was 
significant.   
 
Table 5. Spearman correlation coefficients and P-values between dairy products and serum 
lipids for the participants who did not use lipid lowering drugs 
                   TDP
1
            Butter          Liquid Milk     Sour Milk         Cheese      Other Products  
  S.lipids   r2     P-V3       r       P-V         r       P-V        r       P-V        r       P-V         r       P-V 
    
   TC      -0.117    0.072        0.004     0.956     -0.047      0.469       -0.084    0.195        0.004    0.957         -0.062     0.337           
  HDL    -0.102    0.287        0.057      0.257      -0.045       0.520       -0.068     0.957       -0.021   0.604         -0.072    0.819   
  LDL      -0.069   0.114        0.074      0.384      -0.042       0.485       -0.003     0.269        0.030    0.747         -0.015    0.268        
   TG         0.014   0.828       -0.113     0.081        0.034        0.604      -0.075      0.251       -0.002   0.978          0.035     0.587 
1 
Total dairy products         
2
Correlation coefficient           
3
P-value 
 
 
 
5.5 Serum lipids in tertile categories of dairy products consumption 
Participants were divided into 3 groups in considering of intake of dairy products (lower, 
medium and higher intake), so that all groups included equal numbers of participants. 
Association between dairy products with serum lipids was analyzed using ANOVA or 
Kruskall-Wallis test. Distribution of some variables were different (normally distributed or 
not), so, the test type was also matched to their distribution type (ANOVA or Kruskal-Wallis 
test). Association between dairy products and serum lipids is shown in tables 6, 7, 8, 9, 10 and 
11.  
As it clearly seen in all tables, there are no statistically significant differences in serum lipids 
levels between the tertile groups using different amounts of dairy products.  
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Table 6. Association between serum lipids with total dairy products intake in tertile groups  
Total dairy products intake g/day 
        Serum Lipids                    Tertile 1              Tertile 2             Tertile 3                 P-Values 
                                               21.5-326.2          326.3-543.2      543.3-1420.3 
Total Cholesterol mmol/l      6.45 ± 1.04
1     
     6.30 ± 1.10        6.12 ± 1.13                 0.179
2
 
LDL Cholesterol  mmol/l     4.62 ± 0.97           4.40 ± 0.97        4.34 ± 0.90                 0.142
2
 
HDL Cholesterol mmol/l      1.23 ± 0.27           1.24 ± 0.30        1.17 ± 0.30                0.373
3
 
Triglycerides        mmol/l      1.82 ± 0.93          1.98 ± 1.41        1.90 ± 1.12                 0.894
3
 
1
Mean ± SD          
2
ANOVA         3Kruskal-Wallis test 
 
 
 
Table 7. Association between serum lipids with butter intake in tertile groups  
Butter intake g/day 
        Serum Lipids                    Tertile 1             Tertile 2            Tertile 3                 P-Values 
                                                  0.00-1.3              1.4-9.9              10-96.2 
Total Cholesterol mmol/l      6.34 ± 1.04
1     
      6.25 ± 1.19        6.28 ± 1.06                0.873
2
 
LDL Cholesterol  mmol/l     4.45 ± 0.90           4.45 ± 1.00        4.45 ± 0.90                 0.994
2
 
HDL Cholesterol mmol/l      1.17 ± 0.24           1.25 ± 0.23        1.23 ± 0.31                0.315
3
 
Triglycerides        mmol/l      2.16 ± 1.54          1.74 ± 0.89        1.79 ± 0.92                 0.112
3
 
1
Mean ± SD          
2
ANOVA         3Kruskal-Wallis test 
 
 
 
Table 8. Association between serum lipids liquid milk intake in tertile groups  
Liquid milk intake g/day 
        Serum Lipids                  Tertile 1               Tertile 2              Tertile 3                P-Values 
                                              0.00-175.7          175.8-379.9        380-1367.3 
Total Cholesterol mmol/l      6.25 ± 1.03
1     
     6.46 ± 1.10         6.16 ± 1.14                0.211
2
 
LDL Cholesterol  mmol/l     4.45 ± 0.12           4.56 ± 0.12        4.35 ± 0.13                 0.410
2
 
HDL Cholesterol mmol/l      1.23 ± 0.27           1.22 ± 0.31        1.19 ± 0.29                0.703
3
 
Triglycerides        mmol/l      1.78 ± 0.91          2.06 ± 1.55        1.86 ± 0.92                 0.651
3
 
1
Mean ± SD          
2
ANOVA         3Kruskal-Wallis test 
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Table 9. Association between serum lipids with cheese intake in tertile groups  
Cheese intake g/day 
        Serum Lipids                    Tertile 1             Tertile 2              Tertile 3                 P-Values 
                                                  0.00-7.5               7.6-25              25.1-142.5 
Total Cholesterol mmol/l        6.23 ± 1.2
1     
       6.38 – 1.10        6.27 ± 0.98                0.6682 
LDL Cholesterol  mmol/l        4.44 ± 1.04          4.47 ± 0.97        4.46 ± 0.83                0.179
2
 
HDL Cholesterol mmol/l        1.20 ± 0.31           1.22 ± 28           1.22 ± 0.28                0.865
3
 
Triglycerides        mmol/l        1.81 ± 0.89          2.03 ± 1.43        1.87 ± 1.17                 0.916
3
 
1
Mean ± SD          
2
ANOVA         3Kruskal-Wallis test 
 
 
 
Table 10. Association between serum lipids with sour milk intake in tertile groups  
Sour milk intake g/day 
        Serum Lipids                     Tertile 1              Tertile 2              Tertile 3              P-Values 
                                                     0.00                   0.1-85                85.1-780 
Total Cholesterol mmol/l        6.40 ± 1.12
1     
      6.12 ± 1.18         6.28 – 1.00               0.3142 
LDL Cholesterol  mmol/l        4.54 ± 1.02          4.33 ± 1.00          4.44 ± 0.83              0.388
2
 
HDL Cholesterol mmol/l        4.45 ± 0.12           1.22 ± 0.33          1.22 ± 0.30              0.904
3
 
Triglycerides        mmol/l        2.00 ± 1.26          1.76 ± 1.01          1.88 ± 1.15               0.228
3
 
1
Mean ± SD          
2
ANOVA         3Kruskal-Wallis test 
 
 
 
Table 10. Association between serum lipids with other dairy products intake in tertile groups  
Other dairy products intake g/day 
        Serum Lipids                    Tertile 1              Tertile 2              Tertile 3                 P-Values 
                                                  0.00-2.1               2.2-26.3           26.4-232.5 
Total Cholesterol mmol/l        6.28 ± 1.10
1     
     6.30 ± 1.05         6.21 ± 1.14                0.632
2
 
LDL Cholesterol  mmol/l        4.46 ± 0.98          4.54 ± 0.91         4.36 ± 0.98                0.507
2
 
HDL Cholesterol mmol/l        1.21 ± 0.28           1.22 ± 0.29        1.20 ± 0.31                 0.828
3
 
Triglycerides        mmol/l        1.77 ± 0.87          1.89 ± 1.01         2.04 ± 1.52                0.797
3
 
1
Mean ± SD          
2
ANOVA         3Kruskal-Wallis test 
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6. DISCUSSION 
6.1 Study design and subjects 
This study assessed the association between consumption of dairy products and serum lipids 
level in subject with the participants who had coronary heart disease background consisting of 
CABG, PTCA, AMIS and AMI.  
Cross sectional study design was used because of having specific population in an enough 
large size as a representative of heart patients in Eastern Finland in a specific period in time 
and also descriptive type because the intake of food of the patients studied after their 
diagnosis; however, this study is not so strong to detect and interpret the associations 
identified completely and also could not get certain conclusion for determining correlation 
between dairy products and serum lipid levels.  
To remove the factors which can involve the analysis and could change the results and 
conclusion, the analysis was done only for the participants who did not use lipid lowering 
drugs [175 men (61% of whole men) and 78 women (60% of whole women)]. There was no 
control group to compare the subjects. Some of the data have got by participants` self 
reporting and may include some mistakes such as in energy intake. As the data shows, energy 
intake was low so that 1731±511 kcal/day in participants who did not used lipid lowering 
drugs (n=253). In men who did not use lipid lowering drugs (n=175) energy intake was equal 
to 1852±457 kcal/day and in women who did not use lipid lowering drugs (n=78) was equal 
to 1416±414 kcal/day. Under-reporting could be mostly probable by omitting or reporting 
lesser than used of foods which contain of fat and cholesterol and even because of their 
knowledge of their disease and dietary recommendations by physicians and nutritionists 
which were contributed on the survey. This issue is one of the significant problems in surveys 
and could lead the survey toward a weaker associations and conclusions.       
 
6.2 Serum lipids and dietary fat intake 
Mean of total cholesterol in whole patients were in high level (6.31 mmol/l); however, in men 
was less (6.11 ± 1.14 mmol/l) than in women (6.78 ± 1.00 mmol/l). The level of total 
cholesterol more than 6.18 mmol/l is considered as a high level, so that these people have two 
times more risk of CHD compare with the people have less than the normal level means 5.17 
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mmol/l according to the American Heart Association definitions (Cholesterol 2013). Mean 
HDL were 1.21 ± 0.30 mmol/l which was in normal range [1.03 mmol/l for men and 1.29 
mmol/l for women are the border line for CHD risk (Cholesterol 2013)] in whole participants; 
however, in women was higher than men; therefore, ratio of TC/HDL in women was less than 
men, so, the risk of heart disease affects were more in men than women although the total 
cholesterol was more in women than men (Harvard University 2013). LDL and triglycerides 
levels in whole participants were also in high level and in the women more than the men.  
Mean intake of total fat in this study was 34.4 E% that is almost similar with Finnish people 
intake of 34E% during the same time period but less than the intake of the Finnish people in 
1970s (Karvetti 1981) and even in 1987 (Virtanen MS 2012), as dietary fat intake changed 
from 1972 to 1997 in Finland considerably (National Public Health Institute 1998).  
MUFA(E%) and PUFA(E%) in participants were 11.41 ± 2.7 and 5.82 ± 1.9 respectively 
which was within recommended level according to the nutrition policy in Finland which has 
been recommended optimal level for the MUFA with10 – 15 E% and PUFA with 5 – 10 E% 
(Virtanen MS 2012).    
Mean intake of cholesterol in men which did not use lipid lowering drugs was 232 mg/d and it 
was lower compare with dietary cholesterol intake in men with AMI in previous studies in 
Scotland (Bolton-Smith et al 1992) and England which was 350 mg/d (Watts et 1994).   
Dairy products are one of the main sources of saturated fatty acids. In this thesis, relation 
between dietary saturated fatty acids and serum lipids was investigated and the correlation 
coefficient and the P-value for saturated fatty acids (E% and g/d) are also calculated to 
evaluate the strength of any association with serum lipids. As findings have been shown, there 
is no relation between saturated fatty intake and serum lipids. This finding is in discrepancy 
with several studies reporting positive relation between saturated fatty acids and serum lipid 
levels (American Heart Association 1997 ) whilst, some studies also confirm and accept 
disaffiliation of saturate fats and serum lipids (Wolanska 2012) . It can be seen that there is no 
association between saturated fatty acids and serum lipids although cross sectional study 
design is not as such strong to detect association between serum lipids and dietary intakes like 
dairy products.  
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 6.3 Association between dairy products consumption and serum lipids  
Liquid milk was used most of the dairy product and butter was the least used. Easy 
consumption even instead of water with meals, favorable product and cheaper price are 
privileges for the milk to use that between dairy products. Besides, afraid the people due to 
high content of saturated fat even in small amount are the reason to use of butter as a least 
dairy product to consume. In addition to butter, cheese is a dairy product which people try to 
reduce eating because of high content of fat; however, it is more favorable than butter because 
of better taste and also more nutrient content like calcium and protein.  
Regardless of some changes in dietary habits in Finland after North Karelia survey for 
saturated fatty acids and dairy products consumption, even so, Finland is one of the countries 
which has higher consumption of dairy products especially for liquid milk so that in 2006 
Finland had highest rate of liquid milk in the world (Goff 2012).         
As it seems in this study, in contrast with generic idea of direct and positive association 
between consumption of dairy products and serum lipids (Chi 2004 & Fornes 2000), the 
collected data, calculations and assessments have clarified that there is no association between 
dairy products and serum lipids. Some other studies also confirm this result (Tolstrup 2006 & 
Ravnskov 2010 & Palcios 2010).  
Tolstrup has been mentioned in their findings that fermented dairy products like cheese and 
yogurt which used from some specific bacteria strains not only does not seem to increase the 
cholesterol level but also shown moderate cholesterol reducing properties.  
Ravnskov in his publications about saturated fats and dairy products and their associations 
with serum lipids also noted that there was only 0.4 % change in cholesterol level when 
saturated fat was decreased 30-40% and also short chain fatty acids from milk 4:0-10:0, 12:0 
and 14:0 were inversely associated with serum cholesterol.   
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7. CONCLUSION 
In this thesis, association and correlation between dairy products intake and serum lipids level 
was studied and investigated. 253 coronary heart disease patients with four different 
diagnoses or treatments consisting of CABG, AMIS, AMI and PTCA were included who did 
not use lipid lowering drugs. 
Participants` characteristics consisted of age (mean age 60.9) and gender (175 men and 78 
women) and the serum lipids were examined and calculated for men and women separately. 
The data showed that all serum lipids were not in the desirable level, so that TC, LDL and TG 
were higher than optimal (the mean levels were 6.31, 4.45 and 1.92 mmol/l, respectively; 
whilst, the optimal is maximum 5.17, 2.58 and 1.13 mmol/l, respectively) and HDL did not 
reach to desirable level (the level was 1.15 mmol/l for men and 1.36 for women; whilst, the 
desirable level is more than 1.55 mmol/l).   
Energy percent of dietary fats (total fat, MUFA, PUFA) were in recommended level (they 
were 33.41; 11.41 and 5.82 and the recommended E% is 25-35; 10-15 and 5-10 respectively); 
however, SAFA E% was more than the recommended (E% was 13 and the recommended 
level is 10).  
Spearman correlation coefficient and P-value between dairy products intakes and serum lipids 
were calculated and after checking the results, no association between them has observed.  
To investigate and find any significant difference between different amount consumption of 
dairy products (low, medium and high intake) and serum lipids, tertile groups was selected; 
however, after calculating there was no significant difference in serum lipids between the 
groups was found.   
 At the end, it deemed that there is no association between dairy products consumption and 
serum lipids. In spite of this result, more surveys and deeper scrutiny in this field is been 
needed because dairy products are an important nutrient source and CHD is one of the main 
reasons for mortality in the world.     
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